Skip to main content
. 2023 May 2;21(Suppl 2):2337. doi: 10.1186/s12889-023-15601-2

Table 2.

Health status of the study population (n = 98) according to the nutritional status

Nutritional status
Total M/RM WN P-valued
Variable Category 100.0% (98) 22.4% (22) 77.6% (76)
Diagnosed conditions
 Comorbidity a None 20.0 (19) 14.3 (3) 21.6 (16) 0.043
1 condition 11.6 (11) - 14.9 (11)
2 conditions 14.3 (14) 28.6 (6) c 10.8 (8)
3 or more conditions 53.7 (51) 57.1 (12) 52.7 (39)
 Chronic diseases a Hypertension 51.6 (49) 42.9 (9) 54.1 (40) 0.365
Cardiovascular 32.6 (31) 47.6 (10) 28.4 (21) 0.097
Vascular 32.6 (31) 33.3 (7) 32.4 (24) 0.938
Arthrosis 32.6 (31) 28.6 (6) 33.8 (25) 0.653
Poliomyelitis 25.3 (24) 28.6 (6) 24.3 (18) 0.693
Osteoporosis 17.9 (17) 14.3 (3) 18.9 (14) 0.625
Diabetes 17.9 (17) 23.8 (5) 16.2 (12) 0.423
Depression 14.7 (14) 9.5 (2) 16.2 (12) 0.445
Lung 12.6 (12) 19.0 (4) 10.8 (8) 0.316
Ménière´s syndrome 8.4 (8) 14.3 (3) 6.8 (5) 0.273
Arthritis 7.4 (7) 19.0 (4) c 4.1 (3) 0.020
Cancer 6.3 (6) 14.3 (3) 4.1 (3) 0.089
Other osteoarticular 5.3 (5) 9.5 (2) 4.1 (3) 0.322
Parkinson´s disease 2.1 (2) - 2.7 (2) 0.446
Epilepsy 1.1 (1) - 4.8 (1) 0.059
 Other disorders a Nocturia 65.2 (58) 75.0 (15) 62.3 (43) 0.295
Balance 58.4 (52) 80.0 (16) c 52.2 (36) 0.026
Dizziness 52.8 (47) 65.0 (13) 49.3 (34) 0.215
Vision 43.8 (39) 50.0 (10) 42.0 (29) 0.527
Feet 38.2 (34) 50.0 (10) 34.8 (24) 0.217
Audition 38.2 (34) 30.0 (6) 40.6 (28) 0.391
Urinary incontinence 23.9 (21) 35.0 (7) 20.6 (14) 0.184
Medication
 Polypharmacy (≥ 5 drugs) a Dk/Da 30.6 (30) 45.5 (10) 26.3 (20) 0.228
No 53.1 (52) 40.9 (9) 56.6 (43)
Yes 16.3 (16) 13.6.0 (3) 17.1 (13)
 Drugs a Dk/Da 31.6 (31) 45.5 (10) 27.6 (21) 0.333
Psychotropic/ anxiolytic 3.1 (3) 4.5 (1) 2.6 (2)
Mixture e 3.1 (3) 4.5 (1) 2.6 (2)
Other drugs 62.2 (61) 45.5 (10) 67.1 (51)
Body composition/metabolism
 BMI a  < 25 22.7 (22) 36.4 (8) 18.7 (14) 0.081
 > 25 77.3 (75) 63.6 (14) 81.3 (61)
 Waist perimeter (cm) b - 99.98 ± 10.59 97.08 ± 13.04 100.83 ± 9.70 0.145
 Thigh perimeter (cm) b - 105.74 ± 10.04 106.55 ± 12.61 105.50 ± 9.25 0.719
 Body fat (%) b - 34.20 ± 11.77 35.59 ± 10.46 33.93 ± 11.34 0.702
 Muscle mass (kg) b - 27.17 ± 5.90 25.26 ± 6.51 27.53 ± 5.78 0.292
 Visceral fat level b - 12.71 ± 4.41 11.00 ± 3.91 13.04 ± 4.46 0.205
 Basal metabolic rate (kcal) b - 1412.59 ± 151.71 1386.67 ± 183.99 1417.55 ± 146.54 0.580
Sleep
 Sleeping hours a Dk/Da 37.8 (37) 27.3 (6) 40.8 (31) 0.347
 < 8 11.2 (11) 18.2 (4) 9.2 (7)
 > 8 51.0 (50) 54.5 (12) 50.0 (38)
 Daytime sleepiness a Normal 94.6 (88) 95.5 (21) 94.4 (67) 0.843
Excessive 5.4 (5) 4.5 (1) 5.6 (4)
Cognitive state a
Dementia 6.3 (6) 18.2 (4) c 2.7 (2) 0.035
Cognitive impairment 54.7 (52) 59.1 (13) 53.4 (39)
Suspected pathology 20.0 (19) 9.1 (2) 23.3 (17)
Normal cognition 18.9 (18) 13.6 (3) 20.5 (15)
Falls
 6 months a - 25.3 (24) 40.9 (9) c 20.5 (15) 0.054
 12 months a - 40.0 (38) 50.0 (11) 37.0 (27) 0.275
 Falls with injuries a - 22.1 (21) 45.5 (10) c 15.1 (11) 0.003
 Types of injuries a Minor
Edema 14.9 (14) 18.2 (4) 13.7 (10) 0.603
Excoriation 9.6 (9) 18.2 (4) 6.8 (5) 0.112
Others 1.1 (1) 4.5 (1) 4.1 (3) 0.929
Serious
Edema 5.3 (5) 13.6 (3) c 2.7 (2) 0.045
Fracture 5.3 (5) 4.5 (1) 5.5 (4) 0.863
Abrasion 1.1 (1) - 1.4 (1) 0.581
Distention 1.1 (1) 4.5 (1) - 0.067
 Fear of falling a Low concern 25.0 (23) 18.2 (4) 27.1 (19) 0.188
Moderate concern 37.0 (34) 27.3 (6) 40.0 (28)
High concern 38.0 (35) 54.5 (12) 32.9 (23)
Degree of dependence
Dk/Da 10.2 (10) 4.5 (1) 11.8 (9) 0.148
Moderate dependence 64.3 (63) 81.8 (18) 59.2 (45)
Independence 25.5 (25) 13.6 (3) 28.9 (22)

aValues expressed as % (n); p-values of Chi-square analysis

bValues expressed as the mean ± standard deviation. p-values of t test analysis. M/RM malnourished or at risk of malnutrition, WN well-nourished, Dk/Da Do not know / Do not answer. p-value < 0.05

cvs. WN subgroup

dp-value of χ2 test or t test

e(psychotropic/anxiolytic + anti-inflammatory or diuretics drugs)